Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Hoth Therapeutics, Inc. (HOTH) had Normalized Pre-Tax Income of $-12.36M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-12.47M |
|
-- |
|
-- |
|
$12.36M |
|
$-12.36M |
|
$-0.11M |
|
$-12.47M |
|
|
Normalized Pre-Tax Income |
$-12.36M |
$-12.47M |
|
$-12.47M |
|
$-12.47M |
|
$-12.36M |
|
$-12.36M |
|
$-12.36M |
|
13.81M |
|
13.81M |
|
$-0.90 |
|
$-0.90 |
|
| Balance Sheet Financials | |
$6.86M |
|
-- |
|
$0.74M |
|
$7.60M |
|
$1.45M |
|
-- |
|
-- |
|
$1.45M |
|
$6.15M |
|
$6.15M |
|
$6.15M |
|
15.51M |
|
| Cash Flow Statement Financials | |
$-9.80M |
|
$-0.30M |
|
$9.31M |
|
$7.04M |
|
$6.25M |
|
$-0.79M |
|
$1.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-202.73% |
|
-202.73% |
|
-164.00% |
|
-202.73% |
|
$0.40 |
|
$-0.71 |
|
$-0.71 |
|